Free Trial

70,000 Shares in Novanta Inc. $NOVT Purchased by Southpoint Capital Advisors LP

Novanta logo with Computer and Technology background

Key Points

  • Southpoint Capital Advisors LP has acquired 70,000 shares of Novanta Inc., valued at approximately $8.95 million, indicating a growing interest from institutional investors in the technology firm.
  • Novanta reported $0.76 earnings per share for the last quarter, surpassing estimates, and projected FY 2025 earnings guidance between $3.220 and $3.360 per share.
  • Despite some hedge funds increasing their stakes, several analysts have recently downgraded Novanta's rating, with a consensus target price now set at $133.00.
  • Interested in Novanta? Here are five stocks we like better.

Southpoint Capital Advisors LP acquired a new stake in shares of Novanta Inc. (NASDAQ:NOVT - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 70,000 shares of the technology company's stock, valued at approximately $8,951,000. Southpoint Capital Advisors LP owned 0.19% of Novanta as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Conestoga Capital Advisors LLC lifted its stake in Novanta by 1.3% in the first quarter. Conestoga Capital Advisors LLC now owns 1,365,252 shares of the technology company's stock valued at $174,575,000 after buying an additional 17,220 shares in the last quarter. Geneva Capital Management LLC lifted its stake in Novanta by 9.5% in the first quarter. Geneva Capital Management LLC now owns 934,035 shares of the technology company's stock valued at $119,435,000 after buying an additional 81,397 shares in the last quarter. T. Rowe Price Investment Management Inc. lifted its stake in Novanta by 1.9% in the first quarter. T. Rowe Price Investment Management Inc. now owns 693,090 shares of the technology company's stock valued at $88,626,000 after buying an additional 12,921 shares in the last quarter. Champlain Investment Partners LLC lifted its stake in Novanta by 45.6% in the first quarter. Champlain Investment Partners LLC now owns 596,190 shares of the technology company's stock valued at $76,235,000 after buying an additional 186,848 shares in the last quarter. Finally, Northern Trust Corp lifted its stake in Novanta by 14.0% in the fourth quarter. Northern Trust Corp now owns 487,688 shares of the technology company's stock valued at $74,504,000 after buying an additional 59,986 shares in the last quarter. Institutional investors and hedge funds own 98.35% of the company's stock.

Novanta Trading Up 0.7%

NASDAQ NOVT traded up $0.75 during trading hours on Friday, reaching $116.10. The company's stock had a trading volume of 247,311 shares, compared to its average volume of 400,842. The firm has a fifty day simple moving average of $122.29 and a 200-day simple moving average of $125.06. The stock has a market cap of $4.18 billion, a P/E ratio of 68.29 and a beta of 1.50. Novanta Inc. has a 52 week low of $98.76 and a 52 week high of $184.11. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.54 and a quick ratio of 1.62.

Novanta (NASDAQ:NOVT - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The technology company reported $0.76 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.74 by $0.02. Novanta had a net margin of 6.41% and a return on equity of 14.70%. The business had revenue of $241.05 million during the quarter, compared to analyst estimates of $237.97 million. During the same quarter last year, the business earned $0.73 EPS. The firm's quarterly revenue was up 2.2% on a year-over-year basis. Novanta has set its FY 2025 guidance at 3.220-3.360 EPS. Q3 2025 guidance at 0.780-0.850 EPS. Equities analysts forecast that Novanta Inc. will post 3.03 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

NOVT has been the topic of a number of research reports. Wall Street Zen lowered shares of Novanta from a "buy" rating to a "hold" rating in a research note on Monday, August 11th. Robert W. Baird decreased their price target on shares of Novanta from $139.00 to $133.00 and set a "neutral" rating on the stock in a research note on Monday, August 11th. One analyst has rated the stock with a Hold rating, According to MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $133.00.

Get Our Latest Analysis on Novanta

Novanta Profile

(Free Report)

Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.

Featured Stories

Institutional Ownership by Quarter for Novanta (NASDAQ:NOVT)

Should You Invest $1,000 in Novanta Right Now?

Before you consider Novanta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novanta wasn't on the list.

While Novanta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.